Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.

1. Weiler H, Isermann BH. Thrombomodulin. J Thromb Haemost 2003; 1: 1515–24. 2. McCachren SS, Diggs J, Weinberg JB et al. Thrombomodulin expression by human blood monocytes and by human synovial tissue lining macrophages. Blood 1991; 78: 3128–32. 3. Satta N, Freyssinet JM, Toti F. The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide. Br J Haematol 1997; 96: 534–42. 4. Wu KK, Aleksic N, Ahn C et al. Thrombomodulin Ala455Val polymorphism and risk of coronary heart disease. Circulation 2001; 103: 1386–9. 5. Le Flem L, Mennen L, Aubry ML et al. Thrombomodulin promoter mutations, venous thrombosis, and varicose veins. Arterioscler Thromb Vasc Biol 2001; 21: 445–51. 6. Reny JL, Laurendeau I, Fontana P et al. The TF-603A/G gene promoter polymorphism and circulating monocyte tissue factor gene expression in healthy volunteers. Thromb Haemost 2004; 91: 248–54. 7. Santucci RA, Erlich J, Labriola J et al. Measurement of tissue factor activity in whole blood. Thromb Haemost 2000; 83: 445–54.